New Generation Vaccines

NOTE EDITORE

Highlighting the latest activities and initiatives of prominent organizations working in the vaccine industry such as the Bill and Melinda Gates Foundation, The Global Alliance for Vaccines and Immunization, WHO, UNICEF, the World Bank, New Generation Vaccines, Fourth Edition, details steps developing countries have taken toward research, development, manufacture, and regulation of several new vaccines for widespread use. This text will: cover the current state-of-the-art techniques in vaccine development – including the successes and the failures trace vaccine development from the bench to public health with regard to both FDA and European Union regulations investigate improved methods for immunizing large populations, and the use of needless vaccinations discuss the advancements in the heavily government-funded areas for developing vaccines against potential bioterror and infectious disease agents as well as the immunization of large population bases for diseases like: Anthrax,Smallpox,Ebola,West Nile,SARS,and others Updated throughout with new cutting-edge information on recent breakthroughs and developments. NEW TO GENERATION VACCINES, FOURTH EDITION: highlights the latest activities of prominent organizations in the vaccine industry covers the current techniques in vaccine development investigates improved methods for immunizing large populations

SOMMARIO

Vaccines and Vaccination in Historical Perspective, Myron M. Levine, Rosanna Lagos, and Jose´ EsparzaDeveloping Vaccines in the Era of Reverse Vaccinology, Rino Rappuoli, Gordon Dougan, and Isabel DelanyInitial Clinical Evaluation of New Vaccine Candidates, Carol O. Tacket and Karen L. KotloffSpecial Issues in Performing Vaccine Trials in Developing Countries, Milagritos D. Tapia, Karen L. Kotloff, Christopher V. Plowe, and Samba O. SowLong-Term Evaluation of Vaccine Performance: Methodological, Issues for Phase III and Phase IV Studies, John D. Clemens, Abdollah Naficy, Malla R. Rao, and Hye-won KooEthical Considerations in the Conduct of Vaccine Trials in Developing Countries , Charles Weijer, Claudio F. Lanata, and Christopher V. PloweVaccine Economics: Assuring That Vaccines Are Developed for and Available in Developing Countries, Amie Batson and Piers WhiteheadDevelopment and Supply of Vaccines: An Industry Perspective, Michel Gre´co and Luc HesselReaching Every Child: Achieving Equity in Global Immunization, R. Bruce Aylward, B. Melgaard, M. Birmingham, J. Lloyd, R. Eggers, J. Bilous, and T. CherianA Paradigm for International Cooperation: The GAVI Alliance, Lisa JacobsEconomic Analyses of Vaccines and Vaccination Programs, Benjamin Schwartz and Mark L. MessonierAn Overview of U.S. Food and Drug Administration Licensure of Vaccines, Lydia A. Falk, Norman Baylor, and Karen MidthunAssuring Vaccine Quality by Strengthening Regulatory Agencies, The Work of the World Health Organization, Julie Milstien, Nora Dellepiane, Lahouari Belgharbi, Liliana Chocarro, and David WoodVaccine Safety, Neal A. Halsey, Robert Ball, and Leslie K. BallManufacturing of Vaccines, Guido Dietrich, Julie Milstien, Suresh Jadhav, and Peter C. StowePolio Eradication: Ongoing Innovation to End an Ancient Scourge, R. Bruce Aylward, Stephen L. Cochi, and David L. HeymannRecent Advances in Immunology That Impact Vaccine Development, Marcelo B. Sztein, Rafi Ahmed, and Shane CrottyModulating Vaccine Responses with Innate Immunity, Bali Pulendran, Jeff Powell, and Richard A. FlavellImmunodominance, Deceptive Imprinting, and Immune Refocusing Technology, Peter L. Nara and George LinStandardization and High-Throughput Measurement of T-Cell Responses to Vaccines, Kent J. Weinhold and Janet S. OttingerTransition to High-Throughput Laboratory Assays to Evaluate Multivalent Vaccines, Sandra Romero-Steiner, George M. Carlone, Helen Baxendale, and David GoldblattThe Challenge of Vaccine Protection in Very Young Infants, Claire-Anne SiegristThe Challenge of Inducing Vaccine Protection in the Elderly, Dietmar Herndler-Brandstetter, Angelika Schwanninger, and Beatrix Grubeck-LoebensteinVaccination and Autoimmunity, Paul-Henri Lambert and Michel GoldmanAdjuvants for the Future, Richard T. Kenney and Alan S. CrossTLR Agonists for Immune Enhancement of Vaccines, Heather L. DavisUse of Genetically or Chemically Detoxified Mutants of Cholera and Escherichia coli Heat-Labile Enterotoxins as Mucosal Adjuvants., Lucy C. Freytag, John D. Clements, Dubravka Grdic Eliasson, and Nils LyckeRecent Developments in Nonliving Antigen Delivery Systems, Derek T. O’HaganVirus-Like Particles as Vaccines and Vaccine Delivery Systems, Kathrin U. Jansen, Margaret E. Conner, and Mary K. EstesSubunit Vaccines Produced Using Plant Biotechnology, Qiang Chen, Hugh S. Mason, Tsafrir Mor, Alec Sutherland, Guy A. Cardineau, Charles J. Arntzen, and Carol O. TacketLipopeptide-Based Vaccines, David C. Jackson, Brendon Y. Chua, Lorena E. Brown, Peter Moyle, and Istvan TothVaccines Based on Dendritic Cell Biology, Silvia B. Boscardin, Michel C. Nussenzweig, Christine Trumpfheller, and Ralph M. SteinmanVaccinia Virus and Other Poxviruses as Live Vectors, Bernard MossReplication-Defective and Competent Adenovirus Recombinants as Vaccine Vectors, Marjorie Robert-Guroff, Gary J. Nabel, and John W. ShiverRNA Virus Replicon Vaccines, Nancy L. Davis and Robert E. JohnstonEngineering of Attenuated Salmonella enterica Serovars for Use as Live Vector Vaccines, James E. Galen, Marcela F. Pasetti, Sharon Tennant, Marcelo B. Sztein, and Myron M. LevineDNA Vaccines, Gary J. Nabel, David C. Kaslow, Jeffrey B. Ulmer, and Margaret A. LiuOverview of Heterologous Prime-Boost Immunization Strategies, Helen McShane, Adrian V. S. Hill, and Andrew McMichaelMucosal Immunization and Needle-Free Injection Devices, Jakub K. Simon, Myron M. Levine, Bruce G. Weniger, and Ana M. H. RestrepoAdvances in Transcutaneous Vaccine Delivery, Robert C. Seid, Jr. and Gregory M. GlennRationalizing Childhood Immunization Programs: The Variation in Schedules and Use of Combination Vaccines, Andrew J. Pollard, Kathryn M. Edwards, and Bernard FritzellMeningococcal Conjugate and Protein-Based Vaccines, Andrew J. Pollard, E. Richard Moxon, and Rino RappuoliPost-Licensure Impact of Haemophilus influenzae Type b and Serogroup C Neisseria meningitidis Conjugate Vaccines in Industrialized Countries, Elizabeth Miller, Helen Campbell, and Mary RamsayHaemophilus influenzae Type b Disease Burden and the Impact of Programmatic Infant Immunization in Developing Countries, Richard A. Adegbola, Samba O. Sow, and J. Anthony G. ScottPneumococcal Protein-Polysaccharide Conjugate Vaccines, Cynthia G. Whitney and Orin S. LevinePneumococcal Common Proteins and Other Vaccine Strategies, David E. Briles, James C. Paton, Susan K. Hollingshead, and John W. BoslegoPolysaccharide-Based Conjugate Vaccines for Enteric Bacterial Infections: Typhoid Fever, Nontyphoidal Salmonellosis, and Escherichia coli O:H, Shousun C. Szu, John. B. Robbins, Rachel Schneerson, and F.-Y. LinAttenuated Strains of Salmonella enterica Serovars Typhi and Paratyphi as Live Oral Vaccines Against Enteric Fever, Myron M. Levine, James E. Galen, Marcela F. Pasetti, and Marcelo B. SzteinOral Cholera Vaccines, Jan Holmgren and James B. KaperNovel Vaccines Against Tuberculosis, Marcus A. Horwitz, Peter Andersen, and Stefan H. E. KaufmannInfluenza, John Treanor, Wendy Keitel, and Iain StephensonChimeric Vaccines Against Japanese Encephalitis, Dengue, and West Nile, Konstantin V. Pugachev, Farshad Guirakhoo, Dennis W. Trent, and Thomas P. MonathVaccines Against Rotavirus Gastroenteritis, Richard L. Ward, H. Fred Clark, Paul A. Offit, Umesh D. Parashar, and Roger I. GlassNovel Strategies for Immunizing Infants in Developing Countries Who Are Too Young to Receive the Currently Licensed Measles Vaccines, Marcela F. Pasetti, Karina Ramirez, Karen L. Kotloff, Eileen M. Barry, and Myron M. LevineChallenges and Prospects for the Development of an HIV Vaccine, Barney S. Graham and Gary J. NabelVaccine Strategies to Prevent Dengue, Robert Edelman, Stephen S. Whitehead, and David W. VaughnVaccination Against the Hepatitis C Virus, Sergio Abrignani, Raffaele De Francesco, and Michael HoughtonVaccines Against Respiratory Syncytial Virus and Parainfluenza Viruses, Alexander Schmidt, Emmalene Bartlett, Anne Schaap-Nutt, Peter L. Collins, Brian R. Murphy, and Ruth KarronCytomegalovirus Vaccines, David I. Bernstein and Stanley A. PlotkinEpstein–Barr Virus Vaccines, Viviana P. Lutzky and Denis J. MossHerpes Simplex Vaccines, David M. Koelle, Lawrence R. Stanberry, Reuben S. Carpenter, and Richard J. WhitleyDevelopment of Vaccines to Prevent Group A Streptococcal Infections and Rheumatic Fever, J. B. Dale, M. Batzloff, Michael F. Good, J. McCarthy, J. R. Carapetis, P. P. Cleary, V. Fischetti, and J. ZabriskiVaccines Against Group B Streptococcus, Morven S. Edwards, Carol J. Baker, and Lawrence C. PaolettiOverview of Live and Subcellular Vaccine Strategies Against Shigella,.Karen L. Kotloff, Eileen M. Barry, Myron M. Levine, Thomas L. Hale, and Philippe SansonettiVaccines Against Enterotoxigenic Escherichia coli, Ann-Mari Svennerholm and Gregory GlennMultivalent Shigella Enterotoxigenic Escherichia coli Vaccine, Eileen M. Barry and Myron M. LevineVaccines for Staphylococcus aureus Infections, Juliane Bubeck Wardenburg, Dominique Missiakas, and Olaf

AUTORE

Myrone M. Levine, Gordon Dougan, Michael F. Good, Gary J. Nabel, James P. Nataro, Rino Rappuoli

ALTRE INFORMAZIONI

• Condizione: Nuovo
• ISBN: 9781138113824
• Dimensioni: 11 x 8.5 in Ø 7.23 lb
• Formato: Brossura
• Illustration Notes: 100 b/w images
• Pagine Arabe: 1040